Loading…

to bookmark your favorites and sync them to your phone or calendar.

Type: Executive Interview clear filter
Wednesday, January 22
 

11:00am EST

Real Sustainability in Drug Manufacturing
Wednesday January 22, 2025 11:00am - 11:15am EST
Ecolab EVP Hayley Crowe talks with former Catalent CEO John Chiminski on what it takes to improve manufacturing cost and reduced risk profile while improving sustainability.
Moderators
avatar for John Chiminski

John Chiminski

Former Chief Executive Officer, Catalent, Inc.
John Chiminski was named Chief Executive Officer of Catalent, Inc. in March 2009 and appointed Chair of the Catalent Board in October 2016. He then served as Catalent’s Executive Chair from June 2022 to June 2023, as part of a planned succession of a new CEO and transition to an... Read More →
Speakers
avatar for Hayley Crowe

Hayley Crowe

Executive Vice President and General Manager, Global Life Sciences, Ecolab
Hayley Crowe is the executive vice president and general manager of Ecolab’s Global Life Sciences sector, comprised of Ecolab’s Bioprocessing and Purification Technologies and Pharma and Personal Care businesses. Crowe is responsible for delivering value to our pharmaceutical... Read More →
Wednesday January 22, 2025 11:00am - 11:15am EST
Virtual

11:15am EST

Old Flames: Why Oral Drugs are Still Attractive!
Wednesday January 22, 2025 11:15am - 11:30am EST
Adare CEO Tom Sellig talks with former Catalent CEO John Chiminski on why oral small molecules remains an important and attractive market segment
Moderators
avatar for John Chiminski

John Chiminski

Former Chief Executive Officer, Catalent, Inc.
John Chiminski was named Chief Executive Officer of Catalent, Inc. in March 2009 and appointed Chair of the Catalent Board in October 2016. He then served as Catalent’s Executive Chair from June 2022 to June 2023, as part of a planned succession of a new CEO and transition to an... Read More →
Speakers
avatar for Tom Sellig

Tom Sellig

Chief Executive Officer, Adare Pharma Solutions
Tom Sellig brings more than 30 years of global experience in the life sciences industry to Adare, including experience scaling organizations and driving growth in the CDMO and Pharma Services space.   From 2019 to 2021 Tom served as Chief Executive Officer of LabConnect, a clinical... Read More →
Wednesday January 22, 2025 11:15am - 11:30am EST
Virtual

11:30am EST

Building a new leading CDMO for Global Reliable Supply
Wednesday January 22, 2025 11:30am - 11:45am EST
In an age of geopolitical tensions, Bora CEO Bobby Sheng talks with Fierce about bulding a new mega CDMO that provides global reliable supply
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Bobby Sheng

Bobby Sheng

CEO, Bora Pharmaceuticals
Bobby Sheng is the Chairman and CEO of Bora Pharmaceuticals, the preeminent pharmaceutical manufacturing company in Taiwan. Under his visionary leadership, Bora Pharmaceuticals has established itself as a formidable force in the industry, renowned for its innovative and efficient... Read More →
Wednesday January 22, 2025 11:30am - 11:45am EST
Virtual

11:45am EST

Executive Interview: Kevin Conroy, CEO, Exact Sciences
Wednesday January 22, 2025 11:45am - 12:05pm EST
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Kevin Conroy

Kevin Conroy

Chairman and CEO, Exact Sciences, Exact Sciences
Kevin Conroy became CEO of Exact Sciences in 2009 and Chairman in 2014, transforming the organization into one of the world’s premier cancer diagnostics companies with more than 6,500 employees. Under his leadership, Exact Sciences is working to change the future of cancer care... Read More →
Wednesday January 22, 2025 11:45am - 12:05pm EST
Virtual

1:00pm EST

Executive Interview: Bahija Jallal, PhD, CEO, Immunocore
Wednesday January 22, 2025 1:00pm - 1:20pm EST
Moderators
avatar for Darren Incorvaia

Darren Incorvaia

Staff Writer, Fierce Biotech
Darren Incorvaia is a staff writer for Fierce Biotech. He joined Fierce in 2024 and has also written for The New York Times, Science, and Science News, among others. He was an early-career fellow at The Open Notebook in 2023 and has a Ph.D. in Ecology, Evolution and Behavior from... Read More →
Speakers
avatar for Bahija Jallal, PhD

Bahija Jallal, PhD

CEO, Immunocore
Dr Bahija Jallal is Chief Executive Officer and Director of the Board of Immunocore. Before joining Immunocore in January 2019, she served as President of MedImmune, AstraZeneca’s global biologics research and development unit. She was also Executive Vice President of AstraZeneca... Read More →
Wednesday January 22, 2025 1:00pm - 1:20pm EST
Virtual

2:40pm EST

Panel: End of the Conglomerate Era
Wednesday January 22, 2025 2:40pm - 3:20pm EST
Across the medtech industry, some of the largest players have shed entire divisions as they seek to narrow their focus on their core businesses. These moves range from J&J spinning out its Kenvue consumer operations, to Baxter selling off its multibillion-dollar kidney care unit, to GE HealthCare keeping the name of its conglomerate parent as it became an independent company. During this panel, we’ll explore the forces driving these divestitures and their effects on competition, branding, M&A and the broader market landscape—as well as whether elder firms have found success with smaller portfolios, and if the newcomers have found their footing.
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Arda Ural, PhD

Arda Ural, PhD

Americas Life Sciences Leader, Ernst & Young LLP
Arda Ural, PhD is the EY Americas Life Sciences Sector Leader. In this role, he is in service to EY life sciences professionals in North and South America, helping them to solve our clients’ most pressing issues at the C-suite level, building a sector community and upholding the... Read More →
avatar for Brian Montgomery

Brian Montgomery

Chief Strategy Officer, GE HealthCare
Brian leads Strategy for GE HealthCare, responsible for accelerating GE HealthCare’s strategic goals and leading the business development function.Immediately prior to his appointment, Brian was the acting Chief Financial Officer of GE HealthCare from June 2020 after serving as... Read More →
avatar for Ginny Blocki

Ginny Blocki

SVP, Global Marketing & Product Management, embecta
Ginny Blocki serves as the SVP, Global Marketing & Product Management of embecta, where she helped lead the business through a spinoff into an independent, publicly traded company. Since the spinoff, Ginny has been an integral part of the leadership team, focusing on corporate priorities... Read More →
avatar for Rachel Ellingson

Rachel Ellingson

Senior Vice President, Chief Administrative Officer, Zimmer Biomet
Rachel Ellingson was appointed Senior Vice President, Chief Administrative Officer in June 2024. In her role, she is responsible for strategy, business development (M&A execution and integration, strategic partnerships, divestitures and minority investments), as well as marketing... Read More →
Wednesday January 22, 2025 2:40pm - 3:20pm EST
Virtual

3:40pm EST

Executive Interview: Sean Salmon, EVP & President, Cardiovascular, Medtronic
Wednesday January 22, 2025 3:40pm - 4:00pm EST
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Sean Salmon

Sean Salmon

Executive Vice President and President for the Cardiovascular Portfolio, Medtronic
Sean Salmon serves as Executive Vice President and President for the Cardiovascular Portfolio.Sean is responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all Operating... Read More →
Wednesday January 22, 2025 3:40pm - 4:00pm EST
Virtual
 
Thursday, January 23
 

9:30am EST

Executive Interview: Victor Bulto, President, Novartis US
Thursday January 23, 2025 9:30am - 9:50am EST
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Victor Bulto

Victor Bulto

President, US, Novartis
As President of the US unit for Novartis, Victor Bulto is pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.Victor is driven by the pressing need to translate... Read More →
Thursday January 23, 2025 9:30am - 9:50am EST
Virtual

11:10am EST

Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals
Thursday January 23, 2025 11:10am - 11:30am EST
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Nelson Ambrogio

Nelson Ambrogio

President of Radiology, Bayer Pharmaceuticals
Nelson Ambrogio, President Radiology at Bayer, is a global healthcare leader with a career spanning more than 25 years with Bayer. Before joining Radiology in the beginning of 2024, he has been leading the Oncology Franchise for Bayer Pharmaceuticals in the United States, overseeing... Read More →
Thursday January 23, 2025 11:10am - 11:30am EST
Virtual

11:30am EST

The CRDMO Advantage
Thursday January 23, 2025 11:30am - 11:45am EST
Dr. Armin Spura, CEO of BioDuro, talks to Expert Insights' Dr. Kurt Nielsen on how BioDuro's new integrated global CRO + CDMO model can accelerate translational science and the path from discovery to First-in-Human trials.
Moderators
avatar for Kurt Nielsen, Ph.D.

Kurt Nielsen, Ph.D.

Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development... Read More →
Speakers
avatar for Armin Spura, PhD

Armin Spura, PhD

Chief Executive Officer, BioDuro
Dr. Armin Spura joined BioDuro from Crown Bioscience, where he served as the Chief Executive Officer (CEO) for nearly five years, guiding the company through significant growth and strategic development. Throughout his career, Armin has held senior leadership positions at well-known... Read More →
Thursday January 23, 2025 11:30am - 11:45am EST
Virtual

11:45am EST

New Approaches for Bringing Advanced Biologics to Clinic Faster
Thursday January 23, 2025 11:45am - 12:00pm EST
Darren Head, CEO and Chair of Bionova and Board member of Cellipont Bioservices, talks with Expert Insights' Dr. Kurt Nielsen on running two new CDMOs to bring advanced biologics to clinic faster.
Moderators
avatar for Kurt Nielsen, Ph.D.

Kurt Nielsen, Ph.D.

Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development... Read More →
Speakers
avatar for Darren Head

Darren Head

Chairman & President, Bionova Scientific
Darren Head is Chairman & President of Bionova Scientific. He also served as Chairman of Bionova’s Board of Directors from 2019 until the company was acquired by Asahi Kasei in 2022. Darren also serves as CEO of Cellipont Bioservices, a cell therapy CDMO based in the San Diego area.Prior... Read More →
Thursday January 23, 2025 11:45am - 12:00pm EST
Virtual

12:00pm EST

Scaling Complex Orals to Launch
Thursday January 23, 2025 12:00pm - 12:15pm EST
Dr. Dan Smithey, CEO of Serán Bioscience, talks with Expert Insights' Dr. Kurt Nielsen about solving the most complex oral drug development and manufacturing challenges with innovative approaches and new technologies.
Moderators
avatar for Kurt Nielsen, Ph.D.

Kurt Nielsen, Ph.D.

Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development... Read More →
Speakers
avatar for Dr. Dan Smithey

Dr. Dan Smithey

President, CEO and Co-founder, Serán BioScience
Dr. Smithey is the President, CEO and Co-founder of Serán BioScience.  Over his 30-year career, he has led multiple research and development projects in a broad range of therapeutic areas.   His work has led to the successful development of several novel medicines, including Tucatinib... Read More →
Thursday January 23, 2025 12:00pm - 12:15pm EST
Virtual

1:05pm EST

Executive Interview: Keiko Oishi, President & COO, CMIC Holdings Co., Ltd.
Thursday January 23, 2025 1:05pm - 1:25pm EST
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Keiko Oishi

Keiko Oishi

President & COO, CMIC HOLDINGS Co., Ltd.
Thursday January 23, 2025 1:05pm - 1:25pm EST
Hyatt Regency San Francisco
 
Friday, January 24
 

9:30am EST

Executive Interview: Quita Highsmith, Vice President and Chief Diversity Officer, Genentech
Friday January 24, 2025 9:30am - 9:50am EST
Moderators
avatar for Darren Incorvaia

Darren Incorvaia

Staff Writer, Fierce Biotech
Darren Incorvaia is a staff writer for Fierce Biotech. He joined Fierce in 2024 and has also written for The New York Times, Science, and Science News, among others. He was an early-career fellow at The Open Notebook in 2023 and has a Ph.D. in Ecology, Evolution and Behavior from... Read More →
Speakers
avatar for Quita Highsmith

Quita Highsmith

Vice President and Chief Diversity Officer, Genentech
Quita Highsmith is Vice President and Chief Diversity Officer at Genentech, a member of the Roche Group. At Genentech Quita was selected as the first Chief Diversity Officer in the 46-year history of the company and reports to the CEO. She is responsible for enterprise-wide strategic... Read More →
Friday January 24, 2025 9:30am - 9:50am EST
Virtual
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.